{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:51:33Z","timestamp":1790718693301,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Microbiol"],"DOI":"10.1038\/s41564-019-0402-0","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T20:26:26Z","timestamp":1553027186000},"page":"933-940","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Immunoproteasome activation enables human TRIM5\u03b1 restriction of HIV-1"],"prefix":"10.1038","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1726-8033","authenticated-orcid":false,"given":"Jose M.","family":"Jimenez-Guarde\u00f1o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9451-6117","authenticated-orcid":false,"given":"Luis","family":"Apolonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0548-7690","authenticated-orcid":false,"given":"Gilberto","family":"Betancor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7699-2064","authenticated-orcid":false,"given":"Michael H.","family":"Malim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,18]]},"reference":[{"key":"402_CR1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature09907","volume":"472","author":"JW Schoggins","year":"2011","unstructured":"Schoggins, J. W. et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472, 481\u2013485 (2011).","journal-title":"Nature"},{"key":"402_CR2","doi-asserted-by":"publisher","first-page":"a006940","DOI":"10.1101\/cshperspect.a006940","volume":"2","author":"MH Malim","year":"2012","unstructured":"Malim, M. H. & Bieniasz, P. D. HIV restriction factors and mechanisms of evasion. Cold Spring Harb. Perspect. Med. 2, a006940 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"402_CR3","doi-asserted-by":"publisher","first-page":"9254","DOI":"10.1128\/JVI.00854-10","volume":"84","author":"C Goujon","year":"2010","unstructured":"Goujon, C. & Malim, M. H. Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells. J. Virol. 84, 9254\u20139266 (2010).","journal-title":"J. Virol."},{"key":"402_CR4","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nrmicro3449","volume":"13","author":"T Doyle","year":"2015","unstructured":"Doyle, T., Goujon, C. & Malim, M. H. HIV-1 and interferons: who\u2019s interfering with whom? Nat. Rev. Microbiol. 13, 403\u2013413 (2015).","journal-title":"Nat. Rev. Microbiol."},{"key":"402_CR5","doi-asserted-by":"publisher","first-page":"e13521","DOI":"10.1371\/journal.pone.0013521","volume":"5","author":"KM Cheney","year":"2010","unstructured":"Cheney, K. M. & McKnight, A. Interferon-alpha mediates restriction of human immunodeficiency virus type-1 replication in primary human macrophages at an early stage of replication. PLoS ONE 5, e13521 (2010).","journal-title":"PLoS ONE"},{"key":"402_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12542","volume":"502","author":"C Goujon","year":"2013","unstructured":"Goujon, C. et al. Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature 502, 559\u2013562 (2013).","journal-title":"Nature"},{"key":"402_CR7","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nature12653","volume":"502","author":"M Kane","year":"2013","unstructured":"Kane, M. et al. MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature 502, 563\u2013566 (2013).","journal-title":"Nature"},{"key":"402_CR8","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.chom.2013.08.015","volume":"14","author":"Z Liu","year":"2013","unstructured":"Liu, Z. et al. The interferon-inducible MxB protein inhibits HIV-1 infection. Cell Host Microbe 14, 398\u2013410 (2013).","journal-title":"Cell Host Microbe"},{"key":"402_CR9","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nature02343","volume":"427","author":"M Stremlau","year":"2004","unstructured":"Stremlau, M. et al. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427, 848\u2013853 (2004).","journal-title":"Nature"},{"key":"402_CR10","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nature02777","volume":"430","author":"DM Sayah","year":"2004","unstructured":"Sayah, D. M., Sokolskaja, E., Berthoux, L. & Luban, J. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 430, 569\u2013573 (2004).","journal-title":"Nature"},{"key":"402_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0014-5793(94)80612-8","volume":"343","author":"K Akiyama","year":"1994","unstructured":"Akiyama, K. et al. Replacement of proteasome subunits X and Y by LMP7 and LMP2 induced by interferon-gamma for acquirement of the functional diversity responsible for antigen processing. FEBS Lett. 343, 85\u201388 (1994).","journal-title":"FEBS Lett."},{"key":"402_CR12","doi-asserted-by":"crossref","first-page":"10515","DOI":"10.1016\/S0021-9258(19)50047-3","volume":"267","author":"CP Ma","year":"1992","unstructured":"Ma, C. P., Slaughter, C. A. & DeMartino, G. N. Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (macropain). J. Biol. Chem. 267, 10515\u201310523 (1992).","journal-title":"J. Biol. Chem."},{"key":"402_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nri2687","volume":"10","author":"M Groettrup","year":"2010","unstructured":"Groettrup, M., Kirk, C. J. & Basler, M. Proteasomes in immune cells: more than peptide producers? Nat. Rev. Immunol. 10, 73\u201378 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"402_CR14","doi-asserted-by":"crossref","unstructured":"Wagner, J. M. et al. General model for retroviral capsid pattern recognition by trim5 proteins. J. Virol. 92, e01563-17 (2018).","DOI":"10.1128\/JVI.01563-17"},{"key":"402_CR15","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/gt.2010.40","volume":"17","author":"QT Pham","year":"2010","unstructured":"Pham, Q. T., Bouchard, A., Grutter, M. G. & Berthoux, L. Generation of human TRIM5alpha mutants with high HIV-1 restriction activity. Gene Ther. 17, 859\u2013871 (2010).","journal-title":"Gene Ther."},{"key":"402_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cub.2004.12.042","volume":"15","author":"MW Yap","year":"2005","unstructured":"Yap, M. W., Nisole, S. & Stoye, J. P. A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction. Curr. Biol. 15, 73\u201378 (2005).","journal-title":"Curr. Biol."},{"key":"402_CR17","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.15252\/embj.201490361","volume":"34","author":"AJ Fletcher","year":"2015","unstructured":"Fletcher, A. J. et al. TRIM5alpha requires Ube2W to anchor Lys63-linked ubiquitin chains and restrict reverse transcription. EMBO J. 34, 2078\u20132095 (2015).","journal-title":"EMBO J."},{"key":"402_CR18","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1128\/JVI.01948-15","volume":"90","author":"EM Campbell","year":"2016","unstructured":"Campbell, E. M. et al. TRIM5alpha-mediated ubiquitin chain conjugation is required for inhibition of hiv-1 reverse transcription and capsid destabilization. J. Virol. 90, 1849\u20131857 (2016).","journal-title":"J. Virol."},{"key":"402_CR19","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.virol.2005.12.040","volume":"349","author":"F Diaz-Griffero","year":"2006","unstructured":"Diaz-Griffero, F. et al. Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5. Virol. 349, 300\u2013315 (2006).","journal-title":"Virol."},{"key":"402_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cub.2005.11.045","volume":"16","author":"SL Sawyer","year":"2006","unstructured":"Sawyer, S. L., Wu, L. I., Akey, J. M., Emerman, M. & Malik, H. S. High-frequency persistence of an impaired allele of the retroviral defense gene TRIM5alpha in humans. Curr. Biol. 16, 95\u2013100 (2006).","journal-title":"Curr. Biol."},{"key":"402_CR21","doi-asserted-by":"publisher","first-page":"e4894","DOI":"10.1371\/journal.pone.0004894","volume":"4","author":"L Carthagena","year":"2009","unstructured":"Carthagena, L. et al. Human TRIM gene expression in response to interferons. PLoS ONE 4, e4894 (2009).","journal-title":"PLoS ONE"},{"key":"402_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","volume":"81","author":"D Komander","year":"2012","unstructured":"Komander, D. & Rape, M. The ubiquitin code. Annu. Rev. Biochem. 81, 203\u2013229 (2012).","journal-title":"Annu. Rev. Biochem."},{"key":"402_CR23","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1126\/science.286.5447.2162","volume":"286","author":"T Preckel","year":"1999","unstructured":"Preckel, T. et al. Impaired immunoproteasome assembly and immune responses in PA28-\/- mice. Science 286, 2162\u20132165 (1999).","journal-title":"Science"},{"key":"402_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/35056572","volume":"2","author":"PM Kloetzel","year":"2001","unstructured":"Kloetzel, P. M. Antigen processing by the proteasome. Nat. Rev. Mol. Cell Biol. 2, 179\u2013187 (2001).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"402_CR25","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nm.1978","volume":"15","author":"T Muchamuel","year":"2009","unstructured":"Muchamuel, T. et al. A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis. Nat. Med. 15, 781\u2013787 (2009).","journal-title":"Nat. Med."},{"key":"402_CR26","doi-asserted-by":"publisher","first-page":"10368","DOI":"10.1128\/JVI.01313-13","volume":"87","author":"C Granier","year":"2013","unstructured":"Granier, C. et al. Pressure from TRIM5alpha contributes to control of HIV-1 replication by individuals expressing protective HLA-B alleles. J. Virol. 87, 10368\u201310380 (2013).","journal-title":"J. Virol."},{"key":"402_CR27","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nature20567","volume":"540","author":"CM Ribeiro","year":"2016","unstructured":"Ribeiro, C. M. et al. Receptor usage dictates HIV-1 restriction by human TRIM5alpha in dendritic cell subsets. Nature 540, 448\u2013452 (2016).","journal-title":"Nature"},{"key":"402_CR28","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1086\/598861","volume":"199","author":"S Sewram","year":"2009","unstructured":"Sewram, S. et al. Human TRIM5alpha expression levels and reduced susceptibility to HIV-1 infection. J. Infect. Dis. 199, 1657\u20131663 (2009).","journal-title":"J. Infect. Dis."},{"key":"402_CR29","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s12026-016-8810-1","volume":"64","author":"R Celerino da Silva","year":"2016","unstructured":"Celerino da Silva, R. et al. TRIM5 gene polymorphisms in HIV-1-infected patients and healthy controls from Northeastern Brazil. Immunol. Res. 64, 1237\u20131242 (2016).","journal-title":"Immunol. Res."},{"key":"402_CR30","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1371\/journal.ppat.0040018","volume":"4","author":"D van Manen","year":"2008","unstructured":"vanManen, D. et al. The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection. PLoS Pathog. 4, e18 (2008).","journal-title":"PLoS Pathog."},{"key":"402_CR31","doi-asserted-by":"publisher","first-page":"10548","DOI":"10.1128\/JVI.77.19.10548-10556.2003","volume":"77","author":"M Schindler","year":"2003","unstructured":"Schindler, M. et al. Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles. J. Virol. 77, 10548\u201310556 (2003).","journal-title":"J. Virol."},{"key":"402_CR32","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1126\/science.272.5259.263","volume":"272","author":"L Naldini","year":"1996","unstructured":"Naldini, L. et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263\u2013267 (1996).","journal-title":"Science"},{"key":"402_CR33","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1128\/JVI.02553-12","volume":"87","author":"S Cordeil","year":"2013","unstructured":"Cordeil, S. et al. Evidence for a different susceptibility of primate lentiviruses to type I interferons. J. Virol. 87, 2587\u20132596 (2013).","journal-title":"J. Virol."},{"key":"402_CR34","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1128\/JVI.06157-11","volume":"86","author":"C Ochsenbauer","year":"2012","unstructured":"Ochsenbauer, C. et al. Generation of transmitted\/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages. J. Virol. 86, 2715\u20132728 (2012).","journal-title":"J. Virol."},{"key":"402_CR35","doi-asserted-by":"publisher","first-page":"6626","DOI":"10.1073\/pnas.1304288110","volume":"110","author":"NF Parrish","year":"2013","unstructured":"Parrish, N. F. et al. Phenotypic properties of transmitted founder HIV-1. Proc. Natl Acad. Sci. USA 110, 6626\u20136633 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"402_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1128\/JVI.02247-15","volume":"90","author":"MD Dicks","year":"2015","unstructured":"Dicks, M. D. et al. Oligomerization requirements for MX2-mediated suppression of HIV-1 infection. J. Virol. 90, 22\u201332 (2015).","journal-title":"J. Virol."},{"key":"402_CR37","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0092-8674(94)90502-9","volume":"78","author":"M Treier","year":"1994","unstructured":"Treier, M., Staszewski, L. M. & Bohmann, D. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78, 787\u2013798 (1994).","journal-title":"Cell"},{"key":"402_CR38","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1083\/jcb.201501072","volume":"211","author":"AE Dart","year":"2015","unstructured":"Dart, A. E. et al. PAK4 promotes kinase-independent stabilization of RhoU to modulate cell adhesion. J. Cell. Biol. 211, 863\u2013879 (2015).","journal-title":"J. Cell. Biol."},{"key":"402_CR39","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783\u2013784 (2014).","journal-title":"Nat. Methods"},{"key":"402_CR40","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1247005","volume":"343","author":"O Shalem","year":"2014","unstructured":"Shalem, O. et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343, 84\u201387 (2014).","journal-title":"Science"},{"key":"402_CR41","doi-asserted-by":"crossref","unstructured":"Schaller, T. et al. Effects of inner nuclear membrane proteins SUN1\/UNC-84A and SUN2\/UNC-84B on the EARLY steps of HIV-1 infection. J. Virol. 91, e00463-17 (2017).","DOI":"10.1128\/JVI.00463-17"},{"key":"402_CR42","doi-asserted-by":"publisher","first-page":"e111437","DOI":"10.1371\/journal.pone.0111437","volume":"9","author":"NJ Matheson","year":"2014","unstructured":"Matheson, N. J., Peden, A. A. & Lehner, P. J. Antibody-free magnetic cell sorting of genetically modified primary human CD4+T cells by one-step streptavidin affinity purification. PLoS ONE 9, e111437 (2014).","journal-title":"PLoS ONE"},{"key":"402_CR43","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nature09976","volume":"472","author":"T Pertel","year":"2011","unstructured":"Pertel, T. et al. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472, 361\u2013365 (2011).","journal-title":"Nature"}],"container-title":["Nature Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41564-019-0402-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-019-0402-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-019-0402-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T04:02:22Z","timestamp":1671249742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41564-019-0402-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,18]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6]]}},"alternative-id":["402"],"URL":"https:\/\/doi.org\/10.1038\/s41564-019-0402-0","relation":{},"ISSN":["2058-5276"],"issn-type":[{"value":"2058-5276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,18]]},"assertion":[{"value":"26 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}